💊

Thiotepa Riemser

thiotepa

Hæmatopoietisk stamcelletransplantation;Neoplasmer

✅ Autoriseret Generisk

✅

Ingen aktive alarmer

Denne medicin har ingen igangværende mangel, sikkerhedsbreve eller tilbagekaldelser.

Hvad det bruges til

Thiotepa Riemser is indicated, in combination with other chemotherapy medicinal products: with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients. Thiotepa Riemser is indicated, in combination with other chemotherapy medicinal products: with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients; when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients

⚠️ Patient sikkerhed

Officiel EMA-side

https://www.ema.europa.eu/en/medicines/human/EPAR/thiotepa-riemser